Interest of Telemedicine in Primary Care in an Multidisability Population Institutionalized

NCT07792187 | Not Yet Recruiting

• 2 other identifiers: RC31/24/04272025-A02816-43
• Study Type: interventional
• Target: 62
• Locations: 1 country
• Sites: 5

Brief Summary

Swallowing disorders are common and fall within the scope of primary care (as basic, essential health services accessible to all individuals within a community). These swallowing disorders, strongly linked to the environment, do not require, in the majority of cases, a technical and intrusive evaluation. The main objective of this project is to study the relevance of an assessment of dysphagia by teleconsultation

Conditions

Deglutition Disorders in Disabled Persons

Keywords

telemedicine; deglutition disorders; disabled persons

Outcome Measures

Primary Outcomes (1)

• Recommendations on food textures

  Recommendations regarding food textures will be assessed using the IDDSI (International Dysphagia Diet Standardization Initiative) scale during the V1 telemedicine visit and the V2 outpatient visit 15 days later. This scale consists of 8 categories ranging from 0 ("liquid texture") to 7 ("normal texture"), which are used to assess patients' swallowing abilities. This scale will be used to assess the recommended solid-textured diet (IDDSI 3 to 7) and liquid-textured diet (IDDSI 0 to 4). The relevance between the results of the telemedicine and the outpatient visit will be assessed.

  1 month

Secondary Outcomes (5)

• Evaluation of the satisfaction in the structures team

  1 month

• Description of telemedicine treatment: feasibility

  2 weeks

• Description of telemedicine treatment: evaluation methods

  2 weeks

• Description of care in the hospital sector: feasibility

  1 month

• Description of care in the hospital sector: evaluation methods

  1 month

Study Arms (1)

Patients with a deglutition disorder

EXPERIMENTAL

All participants will have deglutition disorder.

Other: Experimental procedure: swallowing assessment by telemedicine; Other: Standard procedure: day hospitalization

Interventions

Experimental procedure: swallowing assessment by telemedicine OTHER

The teleconsultation will be scheduled by the UVD programming IDE after contact by the structure team. This teleconsultation will take place in the presence of the patient's care assistant as well as medical staff (IDE, occupational therapist, physiotherapist, speech therapist, etc.) from the institution and a doctor specializing in swallowing and a speech therapist for the university hospital. The resident will do a food test under the eyes of CHU specialists. The patient will be able to test several textures (more or less solid/liquid) prepared in the center in order to be more accurate in their daily life. The meal will be in his familiar environment with his usual caregivers and tools. The CHU team will be able to interact directly with the institution's staff in order to have all the information necessary to determine their conclusions : questions, details on the patient's degree of compliance, etc.

Patients with a deglutition disorder

Standard procedure: day hospitalization OTHER

Treatment for swallowing disorders in the hospital sector consists of the patient coming to the university hospital or to a day hospital in order to carry out a swallowing assessment consisting of invasive examinations such as nasofibroscopy (NF), swallowing fluoroscopy (VFS) as well as eating a meal outside the patient's usual context, sometimes in the presence of other people foreign to the patient (source of distractibility and sometimes anxiety).

Patients with a deglutition disorder

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients aged ≥ 18 years living in a medical institution (MAS type, FAM from the ASEI network)
• Indication of a medical swallowing assessment in hospital
• Person affiliated to or beneficiary of a social security system.
• Free, informed and written consent signed by the participant or their guardian

You may not qualify if:

• non-movable patient
• Pregnant woman, Woman of childbearing age without contraception
• any contraindication to nasofibroscopy and/or fluoroscopy

Sponsors & Collaborators

• University Hospital, Toulouse: lead

Study Sites (5)

FAM la Vitarelle

Montauban, 82 000, France

Location

MAS de Granès

Montauban, 82 000, France

Location

Mas Azure

Rieux-Volvestre, 31 310, France

Location

Larrey Hospital - Toulouse University Hospital

Toulouse, 31 059, France

Location

MAS Jean de la Fontaine

Toulouse, 31200, France

Location

MeSH Terms

Conditions

Deglutition Disorders

Condition Hierarchy (Ancestors)

Esophageal Diseases; Gastrointestinal Diseases; Digestive System Diseases; Pharyngeal Diseases; Otorhinolaryngologic Diseases

Study Officials

• Sabine Crestani

  Service ORL - Hôpital Larrey

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Sabine Crestani, MD

CONTACT

05 67 77 81 61; crestani.s@chu-toulouse.fr

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: DIAGNOSTIC
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 24, 2026
• First Posted: August 28, 2026
• Study Start (Estimated): January 1, 2027
• Primary Completion (Estimated): June 1, 2030
• Study Completion (Estimated): June 1, 2030
• Last Updated: August 28, 2026

Record last verified: 2026-08

Data Sharing

• IPD Sharing: Will not share

Locations

FR (5)